Kunal joined BresMed in 2014 and became a Board member in 2019. He has a master’s degree in pharmacy. Kunal began his career in the health industry at Promed (now Sentiss Pharma), in R&D project management. He started developing his health economics and outcomes research (HEOR) and consulting skills at Heron (now Parexel) in systematic reviews and meta-analysis, becoming a senior consultant for the company. At BresMed, Kunal heads up the India operations; he set up the evidence review practice area, and is responsible for the 30+ members of the systematic review team. Kunal is responsible for the technical excellence of evidence reviews. He brings strong business acumen and works closely with the other Board members to set the future direction of the company, aiming to increase BresMed’s global presence while maintaining the quality and viability of the business.
In his spare time, Kunal likes to spend time with his family, read books, watch movies and unwind. Kunal has a keen interest in global affairs and the impact of technology and innovation on the modern world.
Kunal says about BresMed: “I’m proud of BresMed‘s rapid development. We are able to offer a world-class consulting service to clients due to the mentoring and training of first-class employees.”
2019-Present Chief Practice Officer: Evidence Evaluation Consulting BresMed
2016-Present Country Head India BresMed
2014-2019 Head of Systematic Reviews BresMed
2007-2014 Senior Consultant Heron (now Parexel)
2006-2007 Management Trainee R&D Project Management Promed (now Sentiss Pharma)
ISPOR (Europe, US and Asia)